10 Oct 2019 --- ADM has released new clinical data affirming the safety and efficacy of a blend of probiotics when used as a coadjutant therapy to alleviate symptoms in psoriasis patients. The discovery further underscores the blurring of the lines between the food and drug space, and spotlights the role probiotics can play in a holistic approach to disease. As the science investigating psoriasis has yet to deliver a cure for the disease, this clinical study marks a significant step forward to alleviating the symptoms of psoriasis, a disease that affects 2 to 5 percent of the global population.
